China SXT Pharmaceuticals, Inc.
SXTC
$1.46
-$0.04-2.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.25M | -1.25M | -401.30K | -401.30K | 3.30M |
| Total Depreciation and Amortization | 6.90K | 6.90K | 34.30K | 34.30K | 50.20K |
| Total Amortization of Deferred Charges | 216.20K | 216.20K | 44.20K | 44.20K | 40.00K |
| Total Other Non-Cash Items | 646.10K | 646.10K | 17.40K | 17.40K | -3.71M |
| Change in Net Operating Assets | -112.70K | -112.70K | -373.20K | -373.20K | -348.70K |
| Cash from Operations | -494.10K | -494.10K | -678.60K | -678.60K | -674.20K |
| Capital Expenditure | -1.00K | -1.00K | -- | -- | -3.50K |
| Sale of Property, Plant, and Equipment | 12.50K | 12.50K | 20.30K | 20.30K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 6.90K |
| Cash from Investing | 11.50K | 11.50K | 20.30K | 20.30K | 3.40K |
| Total Debt Issued | 154.70K | 154.70K | 3.69M | 3.69M | 686.20K |
| Total Debt Repaid | -919.90K | -919.90K | -39.10K | -39.10K | 287.60K |
| Issuance of Common Stock | 1.38M | 1.38M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -33.80K | -33.80K | -33.80K | -33.80K | -55.20K |
| Cash from Financing | 581.00K | 581.00K | 3.62M | 3.62M | 918.70K |
| Foreign Exchange rate Adjustments | -290.10K | -290.10K | 257.50K | 257.50K | 58.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -191.70K | -191.70K | 3.22M | 3.22M | 306.10K |